80 related articles for article (PubMed ID: 6420560)
1. Synovial cell activation. Studies on the mechanism of action of synovial activator activity.
Hamilton JA
J Rheumatol; 1983 Dec; 10(6):872-80. PubMed ID: 6420560
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of human synovial fibroblast plasminogen activator production by mononuclear cell supernatants.
Hamilton JA; Slywka J
J Immunol; 1981 Mar; 126(3):851-5. PubMed ID: 6161965
[TBL] [Abstract][Full Text] [Related]
3. The stimulation of human synovial fibroblast plasminogen activator activity. Involvement of cyclic AMP and cyclooxygenase products.
Hamilton JA; Leizer T; Lingelbach SR
Biochim Biophys Acta; 1986 Apr; 886(2):195-202. PubMed ID: 2421780
[TBL] [Abstract][Full Text] [Related]
4. Interleukin 1 stimulation of synovial cell plasminogen activator production.
Mochan E; Uhl J; Newton R
J Rheumatol; 1986 Feb; 13(1):15-9. PubMed ID: 3486284
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor beta stimulates urokinase-type plasminogen activator and DNA synthesis, but not prostaglandin E2 production, in human synovial fibroblasts.
Hamilton JA; Piccoli DS; Leizer T; Butler DM; Croatto M; Royston AK
Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7180-4. PubMed ID: 1908092
[TBL] [Abstract][Full Text] [Related]
6. Suppression of lipopolysaccharide-induced tumor necrosis factor-alpha generation from human peripheral blood monocytes by inhibitors of phosphodiesterase 4: interaction with stimulants of adenylyl cyclase.
Seldon PM; Barnes PJ; Meja K; Giembycz MA
Mol Pharmacol; 1995 Oct; 48(4):747-57. PubMed ID: 7476903
[TBL] [Abstract][Full Text] [Related]
7. Plasminogen activator activity of rheumatoid and nonrheumatoid synovial fibroblasts.
Hamilton JA
J Rheumatol; 1982; 9(6):834-42. PubMed ID: 6891721
[TBL] [Abstract][Full Text] [Related]
8. Connective tissue activation. VII. Evidence supporting a role for prostaglandins and cyclic nucleotides.
Castor CW
J Lab Clin Med; 1975 Mar; 85(3):392-404. PubMed ID: 163874
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandins E2 and E1 inhibit cytokine-induced metalloprotease expression in human synovial fibroblasts. Mediation by cyclic-AMP signalling pathway.
DiBattista JA; Martel-Pelletier J; Fujimoto N; Obata K; Zafarullah M; Pelletier JP
Lab Invest; 1994 Aug; 71(2):270-8. PubMed ID: 8078306
[TBL] [Abstract][Full Text] [Related]
10. Peripheral blood mononuclear cells stimulate prostacyclin levels of human synovial fibroblast-like cells.
Hamilton JA; Clarris BJ; Fraser JR; Niall MC
Rheumatol Int; 1985; 5(3):121-5. PubMed ID: 3892636
[TBL] [Abstract][Full Text] [Related]
11. Studies on the control of plasminogen activator production by cultured human embryonic lung cells: requirements for inhibition by corticosteroids.
Rifkin DB; Crowe RM
J Cell Physiol; 1980 Dec; 105(3):417-22. PubMed ID: 7193216
[TBL] [Abstract][Full Text] [Related]
12. Elevations in synovial fluid plasminogen activator in patients with rheumatoid arthritis.
Mochan E; Uhl J
J Rheumatol; 1984 Apr; 11(2):123-8. PubMed ID: 6427461
[TBL] [Abstract][Full Text] [Related]
13. Influence of exogenous growth factors on the expression of plasminogen activators and plasminogen activator inhibitors by cells isolated from normal and healing rabbit ligaments.
Murphy PG; Hart DA
J Orthop Res; 1994 Jul; 12(4):564-75. PubMed ID: 7520487
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of fibroblast growth factors on expression of genes of the plasminogen activator and insulin-like growth factor systems by human breast fibroblasts.
Sieuwerts AM; Martens JW; Dorssers LC; Klijn JG; Foekens JA
Thromb Haemost; 2002 Apr; 87(4):674-83. PubMed ID: 12008951
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of the plasminogen activator activity of human synovial fibroblasts by retinoids.
Hamilton JA
Arthritis Rheum; 1982 Apr; 25(4):432-40. PubMed ID: 7200364
[TBL] [Abstract][Full Text] [Related]
16. Effect of adrenaline and glucocorticoids on monocyte cAMP-specific phosphodiesterase (PDE4) in a monocytic cell line.
Delgado M; Fernández-Alfonso MS; Fuentes A
Arch Dermatol Res; 2002 Jul; 294(4):190-7. PubMed ID: 12111350
[TBL] [Abstract][Full Text] [Related]
17. Modulation of urokinase-type plasminogen activator messenger RNA levels in human synovial fibroblasts by interleukin-1, retinoic acid, and a glucocorticoid.
Vitti G; Hamilton JA
Arthritis Rheum; 1988 Aug; 31(8):1046-51. PubMed ID: 3136776
[TBL] [Abstract][Full Text] [Related]
18. Connective tissue activating peptide III. Induction of synthesis and secretion of plasminogen activator by synovial fibroblasts.
Ragsdale CG; Castor CW; Roberts DJ; Swartz KH
Arthritis Rheum; 1984 Jun; 27(6):663-7. PubMed ID: 6539601
[TBL] [Abstract][Full Text] [Related]
19. Human synovial fibroblast plasminogen activator. Modulation of enzyme activity by antiinflammatory steroids.
Hamilton JH; Bootes A; Phillips PE; Slywka J
Arthritis Rheum; 1981 Oct; 24(10):1296-303. PubMed ID: 7197936
[TBL] [Abstract][Full Text] [Related]
20. Contrasting effects of transforming growth factor-beta and IL-1 on the regulation of plasminogen activator inhibitors in human synovial fibroblasts.
Hamilton JA; Wojta J; Gallichio M; McGrath K; Filonzi EL
J Immunol; 1993 Nov; 151(10):5154-61. PubMed ID: 8228215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
